Human dendritic cells in cancer
Dendritic cells (DCs) are professional antigen-presenting cells, orchestrating innate and adaptive immunity during infections, autoimmune diseases, and malignancies. Since the discovery of DCs almost 50 years ago, our understanding of their biology in humans has increased substantially. Here, we review both antitumor and tolerogenic DC responses in cancer and discuss lineage-specific contributions by their functionally specialized subsets, including the conventional DC (cDC) subsets cDC1 and cDC2, the newly described DC3, and the plasmacytoid DCs (pDCs), focusing on the human setting. In addition, we review the lineage-unrestricted “mature DCs enriched in immunoregulatory molecules” (mregDC) state recently described across different human tumors.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Frontiers in Immunology
16 publications, 8.38%
|
|
|
Nature Communications
7 publications, 3.66%
|
|
|
Cancers
5 publications, 2.62%
|
|
|
International Immunopharmacology
5 publications, 2.62%
|
|
|
OncoImmunology
4 publications, 2.09%
|
|
|
Frontiers in Genetics
3 publications, 1.57%
|
|
|
Immunity
3 publications, 1.57%
|
|
|
Immunology
3 publications, 1.57%
|
|
|
Cell Reports Medicine
3 publications, 1.57%
|
|
|
Cell Reports
3 publications, 1.57%
|
|
|
Journal of Leukocyte Biology
3 publications, 1.57%
|
|
|
British Journal of Cancer
2 publications, 1.05%
|
|
|
Biomedicines
2 publications, 1.05%
|
|
|
Journal of Anatomy
2 publications, 1.05%
|
|
|
Cancer Immunology, Immunotherapy
2 publications, 1.05%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.05%
|
|
|
Science immunology
2 publications, 1.05%
|
|
|
Signal Transduction and Targeted Therapy
2 publications, 1.05%
|
|
|
Medicine (United States)
2 publications, 1.05%
|
|
|
Molecular Cancer
2 publications, 1.05%
|
|
|
Seminars in Immunology
2 publications, 1.05%
|
|
|
European Journal of Immunology
2 publications, 1.05%
|
|
|
International Journal of Biochemistry and Cell Biology
2 publications, 1.05%
|
|
|
Journal of Translational Medicine
2 publications, 1.05%
|
|
|
Genome Biology
2 publications, 1.05%
|
|
|
Neoplasia
2 publications, 1.05%
|
|
|
Cell Proliferation
1 publication, 0.52%
|
|
|
Annals of the Rheumatic Diseases
1 publication, 0.52%
|
|
|
Frontiers in Pediatrics
1 publication, 0.52%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
10
20
30
40
50
60
|
|
|
Elsevier
51 publications, 26.7%
|
|
|
Springer Nature
32 publications, 16.75%
|
|
|
Frontiers Media S.A.
22 publications, 11.52%
|
|
|
Wiley
18 publications, 9.42%
|
|
|
MDPI
17 publications, 8.9%
|
|
|
Cold Spring Harbor Laboratory
11 publications, 5.76%
|
|
|
Taylor & Francis
9 publications, 4.71%
|
|
|
Oxford University Press
5 publications, 2.62%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 1.57%
|
|
|
American Association for Cancer Research (AACR)
3 publications, 1.57%
|
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 1.05%
|
|
|
American Chemical Society (ACS)
2 publications, 1.05%
|
|
|
AME Publishing Company
2 publications, 1.05%
|
|
|
BMJ
1 publication, 0.52%
|
|
|
Walter de Gruyter
1 publication, 0.52%
|
|
|
Research Square Platform LLC
1 publication, 0.52%
|
|
|
Rockefeller University Press
1 publication, 0.52%
|
|
|
IntechOpen
1 publication, 0.52%
|
|
|
Hans Publishers
1 publication, 0.52%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.52%
|
|
|
Spandidos Publications
1 publication, 0.52%
|
|
|
ANO -Perspective of Oncology
1 publication, 0.52%
|
|
|
Bashkir State Medical University
1 publication, 0.52%
|
|
|
The Company of Biologists
1 publication, 0.52%
|
|
|
10
20
30
40
50
60
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.